Acadia Centre for Estuarine ResearchThe Acadia Centre for Estuarine Research (ACER) was established in 1985 following 70 years of interest and study on the potential and implications of tidal power development in the Bay of Fundy. Initial funds were provided by the Secretary of State under the Centres of Specialization Fund, with additional facility and funding support provided by Acadia University.
Neurodyn utilizes a portfolio approach to identify, validate, and develop bioactives for neuroprotection and the early treatment of neurological diseases. Neurodyn identifies bioactive compounds within historically-proven natural treatments with the goal of validating therapeutic candidates and ultimately developing treatments for Parkinson's, Alzheimer's, ALS and chronic nerve pain. Neurodyn will out-license or sell validated therapeutic candidates to pharmaceutical and consumer health players, as well as explore faster alternatives to traditional drug development, such as the US FDA Medical Food designation.Neurodyn's unique insight into the discovery, validation, and development of new bioactive compounds comes from a strong development capacity based on international partners with demonstrated historical knowledge of natural compounds, in-house medicinal chemistry capability, and proprietary animal models of neurological disease.News